HPR21 Characteristics and Treatment Patterns of Tofacitinib Users in Taiwan, 2015-2019
Abstract
Authors
HM Chuang CW Lin WI Huang WJ Kuo WW Chen FYS Hsiao
HM Chuang CW Lin WI Huang WJ Kuo WW Chen FYS Hsiao
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now